Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Magenta Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues27.95.8
            Revenue growth382.5% 
Cost of goods sold35.79.3
Gross profit-7.8-3.5
            Gross margin-28.1%-60.3%
General and administrative7.83.5
EBIT-35.7-9.3
            EBIT margin-128.1%-160.3%
Pre-tax income-35.5-9.4
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income0.00.0
            Net margin-0.1%-0.2%
 
Diluted EPS($19.12)($65.15)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy